Kiran Majumdar-Shaw, CEO of Biocon to do product launch dates, prices, channels and communications mix decisions related to the launch BioMAb, a new cancer drug in India. "Hide
by Sunil Gupta, Das Narayandas Source: Harvard Business School 15 pages. Publication Date: August 28, 2007. Prod. #: 508026-PDF-ENG
Related Case Solutions & Analyses:
UpDown: Confidential Instructions for MICHAEL
Price-Fixing Vignettes
Health Resources & Technology
Implementing Electronic Road Pricing in Singapore: Epilogue (Sequel)
Northwest Airlines and the Detroit Snowstorm (C): Class-Action Status Is Granted to Suits over Northwest Delay
Monmouth Incorporation
Bob Beall at the Cystic Fibrosis Foundation
Magnet beauty products
North American Financial Corporation (NAF) The MLM Project (A)
Daqi Case Report
